RAYDEL is a premium healthcare brand that has been dedicated to the pursuit of innovation and growth for nearly 40 years. RAYDEL is a global supplier, catering to markets in Australia, New Zealand, Korea, Japan, China, Taiwan, Vietnam, Singapore, and Malaysia. With a commitment to growth and expansion, RAYDEL is actively preparing to enter European and American markets, aiming to further solidify its position as a leading player in the international arena while enhancing the quality of life through its innovative products and solutions.
Founded in 1986, RAYDEL AUSTRALIA PTY LTD is a leading GMP licensed manufacturer of health foods and complementary medicines based in Sydney, Australia. It supports its worldwide branches through various means. www.raydel.com.au
Founded in 1994, RAYDEL Korea has become a leader of health functional foods in Korea and is approaching a second leap forward as a total healthcare company covering foods, cosmetics, and biomedicine. www.raydelkorea.co.kr
Founded in 2018, RAYDEL JAPAN provides not only the brand awareness, but also research and knowledge tailored to Japanese people. RAYDEL Japan helps Japanese consumers to improve their quality of life and longevity. www.raydel.co.jp
Founded in 2023 , RAYDEL VIETNAM., JSC provide comprehensive solution for Vietnamese people. RAYDEL Vietnam helps high-quality, and trustworthy healthcare solutions to improve Vietnamese quality of life and longevity.
Human Biomedicine
- Vaccine
- Heberprot-P
- Jusvinza
Animal vaccine
- Porvac
Complementary medicine
Health functional foods (export)
- Policosanol-sugar cane wax alcohols
- Bees wax alcohols (Abexol)
Health foods
- Royal jelly, Sacha inchi oil, Moringa, etc.
Body care
- Ozonated oil
Preclincial Research
Clinical Research
GMP-licensed facility certified by the TGA (Therapeutic Goods Administration of the Australian Government) for manufacturing complementary listed medicines.
Products that enhance the quality of life,
People who spread health benefits to the world.
(Figures represent combined totals across the entire RAYDEL global group.)
AUSTRALIA, KOREA, JAPAN, CHINA, CANADA, SPAIN, HONG KONG, SINGAPORE, MALAYSIA, VIETNAM, MEXICO, UNITED STATES
Including the WIPO(World Intellectual Property Organization) Gold Medal (1993)
(Policosanol-sugar cane wax alcohols, Bees wax alcohols)
boxes (2023, 10mg)
RAYDEL Australia has been selected as a Finalist in not just one, but two prestigious categories in the 2025 NSW Export Awards, presented by the Export Council of Australia. This is a tremendous recognition, and we want to thank you—our customers, partners, and supporters—for being part of this journey.
Read MoreIn an interview with a correspondent from the Vietnam News Agency’s Seoul Bureau, Mr. Lee explained that his story is not about making the perfect decision, but rather about how to approach making the best possible choice.
Read MoreRAYDEL’s Managing Director, Byong Ku Lee received the prestigious Carlos Finlay Medal from the Cuban government. To learn more about his journey and the story behind RAYDEL, visit the CEO’s website at bklee.net
Visit WebsiteRAYDEL proudly sponsored and participated in the 2nd Symposium on the Longevity Factor HDL, held at the Grand Hyatt Seoul. This prestigious event brought together leading researchers to discuss the crucial role of HDL (high-density lipoprotein) in vascular health and longevity.
Read MoreStanford University’s “World’s Top 2% Scientists” list, based on Scopus data and published with Elsevier, recognizes the most influential researchers worldwide. Dr. Kyung Hyun Cho, Head of RAYDEL Research Institute, ranked 98,958th—placing him in the top 1% globally.
Read More
RAYDEL Policosanol, Bees Wax Alcohols(Abexol), Fresh Royal Jelly, Flambo Oil, etc.
Founded on a commitment to lipoprotein science.
Our research began with a focus on identifying substances that elevate high-density lipoprotein (HDL) levels, leading to intensive studies on policosanol-sugarcane wax alcohol.
Research Areas:
HDL
Policosanol - Sugarcane Wax Alcohol
Bees Wax Alcohols (Abexol)
Ozonated Oil
Therapeutic agent for acute severe inflammation (CIGB-258, Jusviza®)
Visit Website